Hikma Pharmaceuticals PLC and its subsidiaries ('Hikma' or 'Group'), the multinational pharmaceutical company, reports its ...

Black communities often experience systemic barriers to care, leading to disparities in colorectal cancer outcomes, according ...

The Royal Marsden Cancer Charity, which supports the work of The Royal Marsden, has commended the significant support of Her ...

The Sharjah Clinical Genomics Laboratory in the UK is advancing research and bringing hope to thousands of cancer patients ...

Galleri multi-cancer early-detection blood test from Grail is the first broadly available screen that can flag more than 50 ...

James Van Der Beek Gives Life Update Amid Cancer Journey: 'I Was So Emotionally Lit Up' first appeared on Parade on Aug 9, ...

Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow after market close. Here’s ...

Guardant Health earns the No. 12 rank among its peers in the Medical-Services industry group. GeneDx Holdings WGS, Hims & Hers Health HIMS and Stevanato Group STVN are among the top 5 highly rated ...

New research reveals that updated colorectal cancer screening among younger Americans has led to significant increases in local-stage tumor detection and diagnoses.

GUARDANT HEALTH INC (NASDAQ: GH) faced a significant sell-off, with ARK parting with 1,419,766 shares for a total of approximately $63.31 million. This trade marks a notable exit from the precision ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

Exact Sciences has a multipronged approach to cancer testing. Its flagship product line is Cologuard, the market leader in stool-based screening for colorectal cancer, or CRC. Its second-largest ...